로딩 중…
지수 로딩 중…
ADBiotech Co., Ltd.
179530· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩2,220+0.23%
2026-06-19
Price Chart
ADBiotech Co., Ltd.-39.01%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 43.69B KRW |
| Revenue | 12.51B KRW |
| Net Income | -3.33B KRW |
| Total Assets | 42.56B KRW |
| Net Assets | 13.57B KRW |
| Employees | 57 |
| Value | |
| P/B | 3.22x |
| P/S | 3.49x |
| FCF Yield | -3.20% |
| Profitability | |
| ROE | -24.53% |
| ROA | -7.82% |
| Op. Margin | -34.86% |
| Revenue Growth | -11.13% |
| Financial Health | |
| Debt Ratio | 313.64% |
| Total Debt | 24.45B KRW |
| FCF | -1.40B KRW |
| Cash | 4.94B KRW |
| Current Ratio | 0.48x |
| Performance | |
| 1Y Return | -39.01% |
| 1M Return | -14.12% |
| From 52W High | -59.27% |
| 1Y MDD | -70.56% |
| Trading | |
| Volume | 78,097 shares |
| Foreign Own. | 1.71% |
| Per Share | |
| EPS | -579 KRW |
| BPS | 781 KRW |
Company Info
Addbio Tech, established in 2000 and headquartered in Chuncheon-si, Gangwon-do, is an eco-friendly biotechnology company researching immune antibodies to develop vaccines and antibiotic alternatives. The company possesses key pipelines, including IgY immune egg yolk antibodies, VHH antibodies, microbial agents, and scFv antibodies, ensuring high stability through both egg-derived and camelid-derived antibody technologies. Addbio Tech is developing products to meet the growing demand for livestock infectious disease solutions and vaccine alternatives, actively expanding its global market presence, particularly through China and Southeast Asia.